Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Clinical Outcomes for Offering Genetic Testing in a Tiered Approach [NA]
A completed clinical trial evaluating the outcomes of offering genetic testing in a tiered approach, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Narrative Visualization for Breast Cancer Survivors' Physical Activity [NA]
Completed clinical trial exploring narrative visualization to support breast cancer survivors' physical activity; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Dexmedetomedine and Ketamine in Erector Spinae Block for Postoperative Analgesia Following Mastectomy. [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating dexmedetomidine and ketamine in erector spinae block for postoperative analgesia after mastectomy has …
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Pink Warrior 2: Teleconference-based Gaming Support [NA]
A completed clinical trial evaluating teleconference-based gaming support for individuals with breast cancer, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update on drug resistance inhibition for women with recurrent or metastatic breast cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-06Clinical Trial Update: Paravertebral Block (PVC) Versus Pectoral Nerve Block (PEC) [Phase 3]
Phase 3 trial comparing paravertebral block to pectoral nerve block in breast cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: A Randomized, Controlled, Open-label Clinical Trial of Adjuvant Intensive Therapy for HR+/ HER2-SNF4 Early Breast Cancer [Phase 3]
A Phase 3 randomized trial evaluating adjuvant intensive therapy in HR+/HER2-negative breast cancer; status is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: Stellate Ganglion Block (SGB) For Women for Breast Cancer [Phase 2]
Phase 2 clinical trial update on Stellate Ganglion Block for hot flashes in women undergoing breast cancer treatment; study completed with r…
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: Pilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast Cancer [Phase 2]
Phase 2 pilot trial assessing 68Ga Bombesin PET/CT (NeoB) imaging for staging in breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Preoperative Treatment of HR+/HER2+Breast Cancer With Pirotinib, Trastuzumab and AI Research [Phase 2]
Phase 2 clinical trial update exploring preoperative treatment of HR+/HER2+ breast cancer with pirotinib, trastuzumab, and an AI-based thera…
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer [Phase 1]
A Phase 1 trial evaluating Infigratinib in combination with Tamoxifen for hormone receptor-positive, HER2-negative FGFR-altered advanced bre…
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients [Phase 3]
Phase 3 trial comparing vinorelbine to gemcitabine plus vinorelbine in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Exercise Program in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy [NA]
A completed clinical trial evaluating an exercise program in breast cancer patients receiving neoadjuvant chemotherapy; results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-30Clinical Trial Update: Pyrotinib After Trastuzumab-based Adjuvant Therapy in Patients With HER2-positive Breast Cancer [Phase 2]
A Phase 2 trial evaluating pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer is ongoing, with …
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: Prospective Study of Particle Radiotherapy for Breast Cancer With Different Arm Position [Phase 2]
Phase 2 prospective trial assessing particle radiotherapy for breast cancer with different arm positions.
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: A Multicenter, Randomized, Open, Phase III Trial of ddEC-THPvs Evaluating the Efficacy and Safety of TCHP Neoadjuvant Therapy for HER2-positive Breast Cancer [Phase 3]
A multicenter, randomized Phase III trial evaluating ddEC-THP versus TCHP neoadjuvant therapy for HER2-positive breast cancer is in Phase 3 …
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation [Phase 1, Phase 2]
Clinical trial update for the DEPO-Trigger trial evaluating DEPOt TRIGGER GnRH agonist for final oocyte maturation in a breast cancer settin…
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression [Phase 4]
A Phase 4 study evaluating vidicizumab in combination with tirelizumab for breast cancer with low HER2 expression; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy [NA]
A completed clinical trial evaluating prone breath-hold technique to reduce cardiac and pulmonary radiation exposure in women receiving left…
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer [Phase 2]
Phase II open-label trial of Tarceva in women with metastatic, hormone- and HER2-negative breast cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX® [Phase 3]
Phase 3 trial comparing LY01005 to ZOLADEX in breast cancer completed, reporting efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum [NA]
A completed clinical trial studying MRI to detect heart damage in cancer patients receiving chemotherapy, with an exercise capacity addendum…
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: A Study With Pembrolizumab in Combination With Dual Anti-HER2 Blockade With Trastuzumab and Pertuzumab in Early Breast Cancer Patients With Molecular HER2-enriched Intrinsic Subtype (Keyriched-1) [Phase 2]
Phase 2 trial evaluating pembrolizumab with dual anti-HER2 blockade (trastuzumab and pertuzumab) in early breast cancer with HER2-enriched s…
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases [Phase 2]
Phase II study update for T-DX in HER2-positive breast cancer with brain metastases has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: Novel MRI Sequence MR Fingerprinting in Breast MRI Feasibility Study [NA]
Feasibility study of a novel MRI sequence (MR Fingerprinting) in breast MRI for breast screening; completed with posted results.